Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Synergy CHC (SNYRQ) Stock Price & Analysis

116 Followers

SNYRQ Stock Chart & Stats

$0.00$0.00(100.00%)
At close: 3:34 PM EDT
$0$0.1$0.2Jul 27Aug 10Aug 24Sep 8Sep 21Oct 5Oct 20
Day’s Range
$0.01 - $0.01
52-Week Range
$0.01 - $2.58
Previous Close
$0.02
Volume
N/A
Average Volume (3M)
54.70M
Market Cap
$4,142
Enterprise Value
$41.94M
Total Cash (Recent Filing)
$292.12K
Total Debt (Recent Filing)
$27.75M
Price to Earnings (P/E)
―
Beta
0.63
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
0.01
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Stable Gross Margin

A relatively steady gross margin near 67% indicates that the company’s products have retained substantial gross-profit contribution despite broader financial deterioration. If maintained, this provides a foundation for eventual operating improvement, although current losses show that gross profit is not yet covering the full cost structure.

Improving Free Cash Flow Trend

The narrowing of the free cash flow deficit versus 2024 is a constructive directional change in cash performance. It suggests some improvement in cash discipline or operating requirements, but the benefit remains limited because free cash flow is still meaningfully negative and does not yet fund debt reduction or reinvestment.

Specialized GI Therapeutic Focus

A defined focus on prescription gastrointestinal therapies gives Synergy CHC a specialized business identity rather than a broad, unfocused healthcare scope. Its association with Trulance and constipation-related indications provides an established therapeutic context that could support focused commercial activity over the medium term.

Bears Say

Declining Revenue

Revenue contraction signals weakening commercial scale and reduces the company’s ability to absorb fixed operating costs. Continued top-line pressure can make it harder to leverage the relatively high gross margin, sustain investment in the business, or move toward breakeven without additional financing or a meaningful improvement in demand.

Deep Operating Losses

Severely negative profitability shows that gross profit is not translating into sustainable earnings after operating expenses. Persistent operating and EBITDA losses can consume capital, restrict strategic flexibility, and make any recovery dependent on materially improving the cost structure or restoring revenue growth.

Stressed Balance Sheet

Debt that substantially exceeds the asset base, combined with consistently negative equity, indicates significant solvency pressure and a severely impaired capital structure. This limits financial flexibility, raises dependence on external funding, and leaves fewer resources available to support operations, investment, or debt repayment.

SNYRQ FAQ

What was Synergy CHC’s price range in the past 12 months?
Synergy CHC lowest stock price was $0.01 and its highest was $2.58 in the past 12 months.
What is Synergy CHC’s market cap?
Synergy CHC’s market cap is $4,142.
When is Synergy CHC’s upcoming earnings report date?
Synergy CHC’s next earnings report is estimated for May 14, 2026 (not yet confirmed), which is 182 days ago.
How were Synergy CHC’s earnings last quarter?
Synergy CHC released its earnings results on Apr 01, 2026. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$0.26.
Is Synergy CHC overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Synergy CHC pay dividends?
Synergy CHC does not currently pay dividends.
What is Synergy CHC’s EPS estimate?
Synergy CHC’s EPS estimate is 0.04.
How many shares outstanding does Synergy CHC have?
Synergy CHC has 20,711,110 shares outstanding.
What happened to Synergy CHC’s price movement after its last earnings report?
Synergy CHC reported an EPS of -$0.23 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went down -8.667%.
Which hedge fund is a major shareholder of Synergy CHC?
Hedge funds hold Synergy CHC shares: the largest hedge-fund position in Synergy CHC is 71,867,376 shares, and hedge funds decreased their holdings by 1.8K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology